Citations (112)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Tracey Varker, Loretta Watson, Kari Gibson, David Forbes & Meaghan L. O’Donnell. (2021) Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin. Journal of Psychoactive Drugs 53:1, pages 85-95.
Read now
Read now
Hartej Gill, Barjot Gill, David Chen-Li, Sabine El-Halabi, Nelson B. Rodrigues, Danielle S. Cha, Orly Lipsitz, Yena Lee, Joshua Daniel Rosenblat, Amna Majeed, Rodrigo B. Mansur, Flora Nasri, Roger Ho & Roger S. McIntyre. (2020) The emerging role of psilocybin and MDMA in the treatment of mental illness. Expert Review of Neurotherapeutics 20:12, pages 1263-1273.
Read now
Read now
Jason B. Luoma, Christina Chwyl, Geoff J. Bathje, Alan K. Davis & Rafael Lancelotta. (2020) A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy. Journal of Psychoactive Drugs 52:4, pages 289-299.
Read now
Read now
Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug & Kim P. C. Kuypers. (2019) Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. Journal of Psychoactive Drugs 51:2, pages 123-134.
Read now
Read now
Stephen Bright & Martin Williams. (2018) Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research. Australian Psychologist 53:6, pages 467-476.
Read now
Read now
Albert Garcia-Romeu & William A. Richards. (2018) Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry 30:4, pages 291-316.
Read now
Read now
E. Papaseit, M. Torrens, C. Pérez-Mañá, R. Muga & M. Farré. (2018) Key interindividual determinants in MDMA pharmacodynamics. Expert Opinion on Drug Metabolism & Toxicology 14:2, pages 183-195.
Read now
Read now
Amy Emerson, Linnae Ponté, Lisa Jerome & Rick Doblin. (2014) History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS). Journal of Psychoactive Drugs 46:1, pages 27-36.
Read now
Read now
Rianne A. de Kleine, Barbara O. Rothbaum & Agnes van Minnen. (2013) Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review. European Journal of Psychotraumatology 4:1.
Read now
Read now
R. L. Carhart-Harris & D. J. Nutt. (2010) User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study. Journal of Substance Use 15:4, pages 283-300.
Read now
Read now
Anees Bahji, Isis Lunsky, Gilmar Gutierrez & Gustavo Vazquez. Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. Journal of Psychoactive Drugs 0:0, pages 1-16.
Read now
Read now
Articles from other publishers (101)
Lewis Leone, Bryan McSpadden, Annamarie DeMarco, Lauren Enten, Rachel Kline & Gregory A. Fonzo. (2024) Psychedelics and Evidence-based Psychotherapy. Psychiatric Clinics of North America 47:2, pages 367-398.
Crossref
Crossref
Bill Brennan & Alex Belser. 2024. EMBARK Psychedelic Therapy for Depression. EMBARK Psychedelic Therapy for Depression.
Julia Colcott, Alexandre A. Guerin, Olivia Carter, Sally Meikle & Gillinder Bedi. (2024) Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis. Neuropsychopharmacology.
Crossref
Crossref
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, Josimar Hernandez Antonio, Philip A. Bonanno, Carolyn MacLeod, Charlotte Pierce, Hunter Carney, Morgan T. Morrison, Charles Saylor, George Danias, Lauren Lepow & Rachel Yehuda. (2024) The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Current Neuropharmacology 22:4, pages 636-735.
Crossref
Crossref
Alessia Marrocu, Hannes Kettner, Brandon Weiss, Richard J Zeifman, David Erritzoe & Robin L Carhart-Harris. (2024) Psychiatric risks for worsened mental health after psychedelic use. Journal of Psychopharmacology 38:3, pages 225-235.
Crossref
Crossref
F. Dellanoce, Z. Dubus, M. Vidal, C. Vigourt & T. Rabeyron. (2024) Une nouvelle prise en charge innovante dans le traitement des troubles de stress post-traumatique : la thérapie assistée par MDMA, approche historique et analyse des protocoles actuels. Pratiques Psychologiques 30:1, pages 37-56.
Crossref
Crossref
Lisa Bouchet, Zachary Sager, Antoine Yrondi, Kabir B Nigam, Brian T Anderson, Stephen Ross, Petros D Petridis & Yvan Beaussant. (2024) Older adults in psychedelic-assisted therapy trials: A systematic review. Journal of Psychopharmacology 38:1, pages 33-48.
Crossref
Crossref
Sascha B. Thal, Paris Baker, Jonathon Marinis, Michelle Wieberneit, Jason M. Sharbanee, Raimundo Bruno, Petra M. Skeffington & Stephen J. Bright. (2023) Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review. Clinical Psychology & Psychotherapy 31:1.
Crossref
Crossref
Leslie W. Miles, Julie L. Valentine, Linda J. Mabey, Elizabeth S. Hopkins, Paige J. Stodtmeister, Reilly B. Rockwood & Alyssa N. H. Moxley. (2023) A Systematic Review of Evidence-Based Treatments for Adolescent and Adult Sexual Assault Victims. Journal of the American Psychiatric Nurses Association.
Crossref
Crossref
William Brennan, Alex R. KelmanAlexander B. Belser. (2023) A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions. Psychedelic Medicine 1:4, pages 218-229.
Crossref
Crossref
Justyna Holka-Pokorska. (2023) Can research on entactogens contribute to a deeper understanding of human sexuality?. Pharmacological Reports 75:6, pages 1381-1397.
Crossref
Crossref
Tehseen Noorani, Gillinder Bedi & Suresh Muthukumaraswamy. (2023) Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials. Psychological Medicine 53:13, pages 5892-5901.
Crossref
Crossref
Aaron S. Wolfgang & Charles W. Hoge. (2023) Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations. Current Psychiatry Reports 25:10, pages 513-532.
Crossref
Crossref
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin Mallard, Daniel E. Roberts, David Erritzoe, Stephen Ross & Robin L. Carhart-Harris. (2023) Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Scientific Reports 13:1.
Crossref
Crossref
José Carlos Bouso, Genís Ona, Maja Kohek, Rafael G. dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar-Córcoles & Joan Obiols-Llandrich. (2023) Hallucinations and Hallucinogens: Psychopathology or Wisdom?. Culture, Medicine, and Psychiatry 47:2, pages 576-604.
Crossref
Crossref
Camilla L. Nord, Beth Longley, Quentin Dercon, Veronica Phillips, Julia Funk, Siobhan Gormley, Rachel Knight, Alicia J. Smith & Tim Dalgleish. (2023) A transdiagnostic meta-analysis of acute augmentations to psychological therapy. Nature Mental Health 1:6, pages 389-401.
Crossref
Crossref
Gillinder Bedi, Susan M Cotton, Alexandre A. Guerin & Henry J Jackson. (2022) MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail. Australian & New Zealand Journal of Psychiatry 57:4, pages 476-481.
Crossref
Crossref
Steve Kisely, Mark Connor, Andrew A Somogyi & Dan Siskind. (2022) A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Australian & New Zealand Journal of Psychiatry 57:3, pages 362-378.
Crossref
Crossref
Patricio Sáez-Briones, Boris Palma, Héctor Burgos, Rafael Barra & Alejandro Hernández. (2023) Aromatic Bromination Abolishes Deficits in Visuospatial Learning Induced by MDMA (“Ecstasy”) in Rats While Preserving the Ability to Increase LTP in the Prefrontal Cortex. International Journal of Molecular Sciences 24:4, pages 3724.
Crossref
Crossref
Genís Ona, Maja Kohek & José Carlos Bouso. (2022) The illusion of knowledge in the emerging field of psychedelic research. New Ideas in Psychology 67, pages 100967.
Crossref
Crossref
Johanna Prugger, Ekin Derdiyok, Jannis Dinkelacker, Cyril Costines & Timo T. Schmidt. (2022) The Altered States Database: Psychometric data from a systematic literature review. Scientific Data 9:1.
Crossref
Crossref
Sanket B. Raut, Padmaja A. Marathe, Liza van Eijk, Rajaraman Eri, Manoj Ravindran, David M. Benedek, Robert J. Ursano, Juan J. Canales & Luke R. Johnson. (2022) Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Pharmacology & Therapeutics 239, pages 108195.
Crossref
Crossref
Ani Gasparyan, Daniela Navarro, Francisco Navarrete & Jorge Manzanares. (2022) Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies. Neuropharmacology 218, pages 109211.
Crossref
Crossref
Arafath Mohamed, Shehla Touheed, Muzammil Ahmed, Mosab Hor & Sara Fatima. (2022) The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?. Cureus.
Crossref
Crossref
Raúl López-Arnau, Jordi Camarasa, Marcel·lí Carbó, Núria Nadal-Gratacós, Pol Puigseslloses, María Espinosa-Velasco, Edurne Urquizu, Elena Escubedo & David Pubill. (2022) 3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs. Frontiers in Psychiatry 13.
Crossref
Crossref
Joost J Breeksema, Bouwe W Kuin, Jeanine Kamphuis, Wim van den Brink, Eric Vermetten & Robert A Schoevers. (2022) Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology 36:10, pages 1100-1117.
Crossref
Crossref
Collin M. Price, Allison A. Feduccia & Katrina DeBonis. (2022) Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology 42:5, pages 464-469.
Crossref
Crossref
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabo, Alan K. Davis, Rafael Lancelotta, Natasha L. Mason & Johannes G. Ramaekers. (2022) The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT). Journal of Neurochemistry 162:1, pages 128-146.
Crossref
Crossref
Hannah N. Saeger & David E. Olson. (2021) Psychedelic‐inspired approaches for treating neurodegenerative disorders. Journal of Neurochemistry 162:1, pages 109-127.
Crossref
Crossref
Ann Inouye & Aaron Wolfgang. (2022) Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review. Cureus.
Crossref
Crossref
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, Kim P. C. Kuypers & Carmela Mento. (2022) Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions. Frontiers in Psychology 13.
Crossref
Crossref
William Brennan & Alexander B. Belser. (2022) Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Frontiers in Psychology 13.
Crossref
Crossref
Elena Argento, Shira Goldenberg, Kathleen Deering, Jennifer Lavalley, Melissa Braschel, Brittany Bingham & Kate Shannon. (2022) Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada. Drug and Alcohol Dependence Reports 3, pages 100044.
Crossref
Crossref
Kimberly W. Smith, Dakota J. Sicignano, Adrian V. Hernandez & C. Michael White. (2021) MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis. The Journal of Clinical Pharmacology 62:4, pages 463-471.
Crossref
Crossref
Clarissa Yates, Jennifer L. Kruse, J. Blair Price, Avril A. B. Robertson & Susannah J. Tye. (2021) Modulating Neuroplasticity: Lessons Learned from Antidepressants and Emerging Novel Therapeutics. Current Treatment Options in Psychiatry 8:4, pages 229-257.
Crossref
Crossref
Sarah Tedesco, Ganeya Gajaram, Shahzad Chida, Arham Ahmad, Meghan Pentak, Marina Kelada, Layth Lewis, Deepa Krishnan, Carolyn Tran, Oladipo T Soetan, Lawrance T Mukona & Ayodeji Jolayemi. (2021) The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis. Cureus.
Crossref
Crossref
Benjamin JG Illingworth, Declan J Lewis, Andrew T Lambarth, Kate Stocking, James MN Duffy, Luke A Jelen & James J Rucker. (2020) A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis. Journal of Psychopharmacology 35:5, pages 501-511.
Crossref
Crossref
N. L. Mason, K. P. C. Kuypers, J. T. Reckweg, F. Müller, D. H. Y. Tse, B. Da Rios, S. W. Toennes, P. Stiers, A. Feilding & J. G. Ramaekers. (2021) Spontaneous and deliberate creative cognition during and after psilocybin exposure. Translational Psychiatry 11:1.
Crossref
Crossref
Natasha L. Mason & Kim P. C. Kuypers. 2021. Ayahuasca Healing and Science. Ayahuasca Healing and Science
117
136
.
Courtney A. Hutchison & Sara K. Bressi. (2018) MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: Implications for Social Work Practice and Research. Clinical Social Work Journal 48:4, pages 421-430.
Crossref
Crossref
Joost J. Breeksema, Alistair R. Niemeijer, Erwin Krediet, Eric Vermetten & Robert A. Schoevers. (2020) Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies. CNS Drugs 34:9, pages 925-946.
Crossref
Crossref
Erwin Krediet, Tijmen Bostoen, Joost Breeksema, Annette van Schagen, Torsten Passie & Eric Vermetten. (2020) Reviewing the Potential of Psychedelics for the Treatment of PTSD. International Journal of Neuropsychopharmacology 23:6, pages 385-400.
Crossref
Crossref
Tingying Chi & Jessica A. Gold. (2020) A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. Journal of the Neurological Sciences 411, pages 116715.
Crossref
Crossref
Ingmar Gorman, Alexander B. Belser, Lisa Jerome, Colin Hennigan, Ben Shechet, Scott Hamilton, Berra Yazar‐Klosinski, Amy Emerson & Allison A. Feduccia. (2020) Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Traumatic Stress 33:2, pages 161-170.
Crossref
Crossref
Kamil KozeraLena CichońKrzysztof M. WilczyńskiMałgorzata Janas-Kozik. (2020) MDMA – hopes and fears associated with therapeutic use in mental disorders. Pharmacotherapy in Psychiatry and Neurology 36:3, pages 187-204.
Crossref
Crossref
Anees Bahji, Ashleigh Forsyth, Dianne Groll & Emily R. Hawken. (2020) Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 96, pages 109735.
Crossref
Crossref
MATTHEW J. BEGOLA & JASON E. SCHILLERSTROM. (2019) Hallucinogens and Their Therapeutic Use: A Literature Review. Journal of Psychiatric Practice 25:5, pages 334-346.
Crossref
Crossref
Terence H. W. Ching. (2019) Intersectional insights from an MDMA-assisted psychotherapy training trial: An open letter to racial/ethnic and sexual/gender minorities. Journal of Psychedelic Studies 4:1, pages 61-68.
Crossref
Crossref
Madeline M. Pantoni & Stephan G. Anagnostaras. (2019) Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose. Pharmacological Reviews 71:3, pages 413-449.
Crossref
Crossref
Patricio Sáez-Briones, Vicente Castro-Castillo, Gabriela Díaz-Véliz, Luis Valladares, Rafael Barra, Alejandro Hernández & Bruce K. Cassels. (2019) Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT). Frontiers in Pharmacology 10.
Crossref
Crossref
Timothy I. Michaels, Jennifer Purdon, Alexis Collins & Monnica T. Williams. (2018) Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature. BMC Psychiatry 18:1.
Crossref
Crossref
Marcela Ot’alora G, Jim Grigsby, Bruce Poulter, Joseph W Van DerveerIIIIII, Sara Gael Giron, Lisa Jerome, Allison A Feduccia, Scott Hamilton, Berra Yazar-Klosinski, Amy Emerson, Michael C Mithoefer & Rick Doblin. (2018) 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology 32:12, pages 1295-1307.
Crossref
Crossref
Susan Schenk & David Newcombe. (2018) Methylenedioxymethamphetamine (MDMA) in Psychiatry. Journal of Clinical Psychopharmacology 38:6, pages 632-638.
Crossref
Crossref
Andrew Gaddis, Stephanie Lake, Kenneth Tupper, Ekaterina Nosova, Katrina Blommaert, Evan Wood & Kora DeBeck. (2018) Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs. Drug and Alcohol Dependence 192, pages 112-117.
Crossref
Crossref
Lee E. Dunlap, Anne M. Andrews & David E. Olson. (2018) Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine. ACS Chemical Neuroscience 9:10, pages 2408-2427.
Crossref
Crossref
Eduardo Ekman Schenberg. (2018) Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development. Frontiers in Pharmacology 9.
Crossref
Crossref
Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, Jonathan M. Wong, Eden V. Barragan, Paige C. Wilson, Kyle F. Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R. Paddy, Whitney C. Duim, Megan Y. Dennis, A. Kimberley McAllister, Kassandra M. Ori-McKenney, John A. Gray & David E. Olson. (2018) Psychedelics Promote Structural and Functional Neural Plasticity. Cell Reports 23:11, pages 3170-3182.
Crossref
Crossref
Sascha B. Thal & Miriam J. J. Lommen. (2018) Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Contemporary Psychotherapy 48:2, pages 99-108.
Crossref
Crossref
Carlos Alberto Yasin Wayhs, Monique dos Reis, Kristiane de Cássia Mariotti, Wanderson Romão, Boniek Gontijo Vaz, Fabiano Barreto, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2018) NBOMe Designer Drugs: GC-MS and LC-QTOF/MS Detection on Blotter Paper by Brazilian Federal Police (Rio Grande do Sul, Brazil). Brazilian Journal of Forensic Sciences, Medical Law and Bioethics 7:3, pages 193-204.
Crossref
Crossref
Harriet de Wit & Michael Sayette. (2018) Considering the context: social factors in responses to drugs in humans. Psychopharmacology 235:4, pages 935-945.
Crossref
Crossref
Matthew Moroz & Robin L. Carhart-Harris. (2018) Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology. Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology.
Allison A. Feduccia, Julie Holland & Michael C. Mithoefer. (2017) Progress and promise for the MDMA drug development program. Psychopharmacology 235:2, pages 561-571.
Crossref
Crossref
Torsten Passie. (2018) The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law 4, pages 205032451876744.
Crossref
Crossref
Leopold Hermle & Felix Schuldt. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
551
565
.
Anya K. Bershad, Melissa A. Miller & Harriet de Wit. (2017) MDMA does not alter responses to the Trier Social Stress Test in humans. Psychopharmacology 234:14, pages 2159-2166.
Crossref
Crossref
Jakob A. Shimshoni, Ilan Winkler, Ezekiel Golan & David Nutt. (2016) Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn-Schmiedeberg's Archives of Pharmacology 390:1, pages 15-24.
Crossref
Crossref
Anya K Bershad, Melissa A Miller, Matthew J Baggott & Harriet de Wit. (2016) The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?. Journal of Psychopharmacology 30:12, pages 1248-1258.
Crossref
Crossref
Ralph J. Koek, Holly N. Schwartz, Stephenie Scully, Jean-Philippe Langevin, Shana Spangler, Arkady Korotinsky, Kevin Jou & Andrew Leuchter. (2016) Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Progress in Neuro-Psychopharmacology and Biological Psychiatry 70, pages 170-218.
Crossref
Crossref
K. P. C. Kuypers, J. Riba, M. de la Fuente Revenga, S. Barker, E. L. Theunissen & J. G. Ramaekers. (2016) Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:18, pages 3395-3403.
Crossref
Crossref
José Carlos Bouso, Eduardo José Pedrero-Pérez, Sam Gandy & Miguel Ángel Alcázar-Córcoles. (2016) Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens. Human Psychopharmacology: Clinical and Experimental 31:5, pages 356-372.
Crossref
Crossref
. 2016. Les addictions. Les addictions
135
142
.
Timothy Amoroso & Michael Workman. (2016) Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy. Journal of Psychopharmacology 30:7, pages 595-600.
Crossref
Crossref
Michael C Mithoefer, Charles S Grob & Timothy D Brewerton. (2016) Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. The Lancet Psychiatry 3:5, pages 481-488.
Crossref
Crossref
Matthew J Baggott, Jeremy R Coyle, Jennifer D Siegrist, Kathleen J Garrison, Gantt P Galloway & John E Mendelson. (2016) Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. Journal of Psychopharmacology 30:4, pages 378-387.
Crossref
Crossref
Leah R. Mursaleen & Jonathan A. Stamford. (2016) Drugs of abuse and Parkinson's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 209-217.
Crossref
Crossref
Alicia L. Danforth, Christopher M. Struble, Berra Yazar-Klosinski & Charles S. Grob. (2016) MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 237-249.
Crossref
Crossref
Leopold Hermle & Felix Schuldt. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
20
.
Gül Dölen. (2015) Oxytocin: Parallel Processing in the Social Brain?. Journal of Neuroendocrinology 27:6, pages 516-535.
Crossref
Crossref
Débora González, Marta Torrens & Magí Farré. (2015) Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Margaret C. Wardle & Harriet de Wit. (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology 231:21, pages 4219-4229.
Crossref
Crossref
C. Michael White. (2014) 3,4-Methylenedioxymethamphetamine’s (MDMA’s) Impact on Posttraumatic Stress Disorder. Annals of Pharmacotherapy 48:7, pages 908-915.
Crossref
Crossref
Charlotte N. Pull & Charles B. Pull. (2014) Current Status of Treatment for Posttraumatic Stress Disorder: Focus on Treatments Combining Pharmacotherapy and Cognitive-Behavioral Therapy. International Journal of Cognitive Therapy 7:2, pages 149-161.
Crossref
Crossref
Rick Doblin, George Greer, Julie Holland, Lisa Jerome, Michael C. Mithoefer & Ben Sessa. (2014) A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”. Human Psychopharmacology: Clinical and Experimental 29:2, pages 105-108.
Crossref
Crossref
Jessica L. Nielson & Julie D. Megler. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca
41
58
.
A.J.D. Nelson, K.E. Thur, C.A. Marsden & H.J. Cassaday. (2013) Paradoxical effects of low dose MDMA on latent inhibition in the rat. Neuropharmacology 67, pages 331-336.
Crossref
Crossref
Peter Oehen, Rafael Traber, Verena Widmer & Ulrich Schnyder. (2012) A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). Journal of Psychopharmacology 27:1, pages 40-52.
Crossref
Crossref
Michael C Mithoefer, Mark T Wagner, Ann T Mithoefer, Lisa Jerome, Scott F Martin, Berra Yazar-Klosinski, Yvonne Michel, Timothy D Brewerton & Rick Doblin. (2012) Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology 27:1, pages 28-39.
Crossref
Crossref
Frank J. Farach, Larry D. Pruitt, Janie J. Jun, Alissa B. Jerud, Lori A. Zoellner & Peter P. Roy-Byrne. (2012) Pharmacological treatment of anxiety disorders: Current treatments and future directions. Journal of Anxiety Disorders 26:8, pages 833-843.
Crossref
Crossref
Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura, Débora González, Magí Farré, Manel J Barbanoj & José Carlos Bouso. (2012) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. Journal of Psychopharmacology 26:7, pages 1026-1035.
Crossref
Crossref
Adam L. Halberstadt, Mahálah R. Buell, Diana L. Price & Mark A. Geyer. (2012) Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacology Biochemistry and Behavior 102:1, pages 88-94.
Crossref
Crossref
M.-H. Ghysel-Laporte, P. Sibille & N. Milan. 2012. Traité De Toxicologie Médico-judiciaire. Traité De Toxicologie Médico-judiciaire
455
505
.
Miranda Olff, Willie Langeland, Anke Witteveen & Damiaan Denys. (2014) A Psychobiological Rationale for Oxytocin in the Treatment of Posttraumatic Stress Disorder. CNS Spectrums 15:8, pages 522-530.
Crossref
Crossref
Sarah E Hetrick, Rosemary Purcell, Belinda Garner & Ruth Parslow. (2010) Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Stephen J. Kish, Jason Lerch, Yoshiaki Furukawa, Junchao Tong, Tina McCluskey, Diana Wilkins, Sylvain Houle, Jeffrey Meyer, Emanuela Mundo, Alan A. Wilson, Pablo M. Rusjan, Jean A. Saint-Cyr, Mark Guttman, D. Louis Collins, Colin Shapiro, Jerry J. Warsh & Isabelle Boileau. (2010) Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study. Brain 133:6, pages 1779-1797.
Crossref
Crossref
Michael N. Gandy, Matthew McIldowie, Katie Lewis, Agata M. Wasik, Danielle Salomonczyk, Keith Wagg, Zak A. Millar, David Tindiglia, Philippe Huot, Tom Johnston, Sherri Thiele, Blake Nguyen, Nicholas M. Barnes, Jonathan M. Brotchie, Mathew T. Martin-Iverson, Joanne Nash, John Gordon & Matthew J. Piggott. (2010) Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity. MedChemComm 1:4, pages 287.
Crossref
Crossref
Laura A. León, Jesus Landeira-Fernandez & Fernando P. Cardenas. (2009) Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress. Behavioural Brain Research 205:1, pages 259-264.
Crossref
Crossref
Fernando Caudevilla Gálligo, Paloma González Tardón & Carmen Fenoll Brotons. (2009) Drogas de síntesis: novedades. FMC - Formación Médica Continuada en Atención Primaria 16:7, pages 383-392.
Crossref
Crossref
PØ Johansen & TS Krebs. (2009) How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale. Journal of Psychopharmacology 23:4, pages 389-391.
Crossref
Crossref
Rafael de la Torre, Elena Puerta & Norberto Aguirre. (2009) Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing. Psychopharmacology 204:2, pages 379-380.
Crossref
Crossref
Arran Frood. (2008) Illegal drug shows promise in treating trauma symptoms. Nature.
Crossref
Crossref
Timothy I. Michaels, Jennifer Purdon, Alexis Collins & Monnica Williams. (2018) Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of the Literature. SSRN Electronic Journal.
Crossref
Crossref